📣 Hot off the press (June 22)! 📖 🤲🏽 Honored to share the publication of findings from the ‘#LivingDonorExtended Time Outcomes’ (#LETO) Study, an ancillary study of the ‘#APOL1 Long-term Kidney Transplantation Outcomes’ (#APOLLO) Network Study: “#Apolipoprotein L1 Gene Genotype and Kidney Outcomes After #LivingKidneyDonation” 🧬 Key finding: APOL1 genotype is a significant risk factor for reduced kidney function following living kidney donation. These results support #APOL1Genotyping for Black living kidney donor candidates in the U.S. to improve risk stratification and informed decision-making. 📄 Read the @JAMAInternalMed article: jamanetwork.com/journals/jam… 🎤 If you’re attending the @ATCMeeting (#ATC) 2026, please join us for presentations on LETO: • June 23, 9:00 AM — Abstract 921, Plenary Session | Ballroom • June 23, 10:09 AM — Abstract 938 | Room 253A 🙏🏽We are grateful to the @NIDDKgov for funding this work and to our outstanding collaborators: Chi-yuan Hsu, Ying Gao, Barry I. Freedman, @MitchellLunn , Anthony Muiru, Mark Schnitzler, Jasmin Divers, @mannonmom, Nicholette Palmer, Amy Karger, @KristaLentine *, and @emp802* | @UCSFTransplant | @slunephrons | @SSMHealthSTL | @slusom | @wakeforestmed | @NebraskaMed | @nyuniversity 🫶🏼 🤝🏽 We look forward to the discussion and to advancing our understanding of #genetic tools that can help improve the safety and long-term outcomes of living kidney donation.🧬 💙💚 #KidneyDonation #Transplantation #LivingDonation #PrecisionMedicine #Genetics #APOL1 #APOLLOStudy #LETO #ClinicalResearch #ATC2026 🦋